Michael R Slater

This inventor holds 20 USPTO granted patents and 5 published patent applications, plus 1 CIPO patent and 6 EPO patents, primarily in Biotechnology Innovations. Top assignees: Promega Corporation, Dnastar, Inc.. Active years: 1993-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michael R Slater. Retrieved from https://idiyas.com/inventor/michael-r-slater

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 20 (Patent Applications = 5)

% Patents Active = 80.0

CIPO Patents = 1 (Patent Applications = 4)

EPO Patents = 6 (Patent Applications = 7)

Average Co-Inventor Count = 5.0

ph-index = 6

Forward Citations = 179(Granted Patents)

Company Filing History:

Years Active: 1993-2025

Loading Chart...

Areas of Expertise:

Luciferases

Coelenterazine

Hydrolase Proteins

Dehalogenase Proteins

Polynucleotides

Directional Cloning

DNA Polymerases

Thermotoga Neapolitana

Nucleotide Sequences

Protein Sequences

Mutant Proteins

20 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12435354 - -derived luciferases, novel coelenterazine substrates, and methods of use (2025-10-07),

2. 12215375 - Oplophorus-derived luciferases, novel coelenterazine substrates, and methods of use (2025-02-04),

3. 11661623 - Oplophorus-derived luciferases, novel coelenterazine substrates, and methods of use (2023-05-30),

4. 10774364 - Oplophorus-derived luciferases, novel coelenterazine substrates, and methods of use (2020-09-15),

5. 10246690 - Mutant hydrolase proteins with enhanced kinetics and functional expression (2019-04-02),

6. 9951373 - Oplophorus-derived luciferases, novel coelenterazine substrates, and methods of use (2018-04-24),

7. 9873866 - Mutant dehalogenase proteins (2018-01-23),

8. 9840730 - Oplophorus-derived luciferases, novel coelenterazine substrates, and methods of use (2017-12-12),

9. 9593316 - Polynucleotides encoding mutant hydrolase proteins with enhanced kinetics and functional expression (2017-03-14),

10. 9469857 - Vectors for directional cloning (2016-10-18),

11. 9371531 - Vectors for directional cloning (2016-06-21),

12. 9018014 - Vectors for directional cloning (2015-04-28),

13. 8748148 - Polynucleotides encoding mutant hydrolase proteins with enhanced kinetics and functional expression (2014-06-10),

14. 8669103 - Oplophorus-derived luciferases, novel coelenterazine substrates, and methods of use (2014-03-11),

15. 8420367 - Polynucleotides encoding mutant hydrolase proteins with enhanced kinetics and functional expression (2013-04-16),

Sure, I can help you with that. Here is the article about inventor Michael R Slater:

Title: Unveiling the Luminary Innovations of Michael R Slater in Madison, WI

Introduction:

Michael R Slater, a prolific inventor based in Madison, WI, has made significant contributions to the field of bioluminescence through his innovative patents and research endeavors.

Latest Patents:

Michael R Slater's latest patents include groundbreaking inventions such as Oplophorus-derived luciferases, novel coelenterazine substrates, and methods of use. These patents involve an isolated polynucleotide encoding a modified luciferase polypeptide and substrates, specifically highlighting the OgLuc variant polypeptide's enhanced luminescence, signal stability, and protein stability compared to the wild-type luciferase.

Career Highlights:

With an impressive portfolio of 18 patents to his name, Michael R Slater has established himself as a leading figure in the field of bioluminescence research. His expertise and dedication have led to pioneering advancements in the development of luciferase-based technologies.

Collaborations:

Throughout his career, Michael R Slater has collaborated with esteemed professionals in the industry, including colleagues such as Keith V Wood and Lance P Encell. His partnerships with companies like Promega Corporation and Dnastar, Inc. have fueled innovation and propelled his inventions to new heights.

Conclusion:

In conclusion, Michael R Slater's remarkable ingenuity and relentless pursuit of scientific excellence have positioned him as a trailblazer in the realm of bioluminescence research. His groundbreaking patents and collaborative efforts exemplify his commitment to pushing the boundaries of innovation and paving the way for future advancements in the field.

If you need more information or assistance, feel free to ask!

Profile summary based on public USPTO records.